4
Changes in Ownership
Definium Therapeutics, Inc. Filed Acc 0001193125-26-285563
Chief Financial Officer sold 3,013 shares at $45.03 ($135,675)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Roberts Brandi Chief Financial Officer | 2026-06-25 | Sale 10b5-1 | −3,013 | $45.03 | $135,675 | 209,487 | D: show line 1 in the form |
| Open-market sales · 3,013 sh · avg $45.03 · $135,675 | |||||||
Loading xslF345X06/ownership.xml…